Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Contraceptive Drugs And Devices Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The market for contraceptive drugs and devices has experienced robust expansion over recent years. This market is projected to expand from $26.98 billion in 2025 to $28.9 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.1%. Historically, this expansion can be linked to several factors, including government-spearheaded family planning programs, a heightened understanding of reproductive health, increasing levels of urbanization and education, broader access to oral contraceptives, and public health initiatives promoting birth control.
The contraceptive drugs and devices market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $38.08 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. This projected growth during the forecast period is driven by increased integration of digital health, a rising demand for non-invasive contraceptive methods, the expansion of telehealth-based prescriptions, a growing emphasis on male contraception research, and supportive reproductive health policies. Noteworthy trends for this period include a greater adoption of long-acting reversible contraceptives, increased use of hormonal combination therapies, a burgeoning demand for female-centric contraceptive solutions, the wider availability of over-the-counter contraceptive products, and enhanced acceptance of digital contraceptive platforms.
Get A Free Sample Report With In-Depth Market Insights:
Contraceptive Drugs And Devices Market Demand Drivers: What’s Powering Industry Growth?
The growing count of government efforts regarding reproductive health is anticipated to stimulate the advancement of the contraceptive drugs and devices market in the future. These government initiatives champion reproductive well-being by fostering awareness, providing funding, and ensuring access to relevant services. The increase in government initiatives concerning reproductive health stems from a heightened acknowledgment of the necessity to tackle crucial matters such as maternal health, family planning, and the availability of fundamental healthcare services, all of which are essential for overall societal welfare and development. Government programs for contraceptive drugs and devices are designed to broaden access to economical and effective family planning solutions, enabling individuals to make informed decisions regarding their reproductive health. As an illustration, in November 2024, the Australian Government Department of Foreign Affairs and Trade, an Australia-based government agency, confirmed that Australia will commit $56.8 million to a fresh program focused on advancing sexual and reproductive health and rights across Southeast Asia. Hence, the rising volume of government initiatives concerning reproductive health is fueling the expansion of the contraceptive drugs and devices market.
Contraceptive Drugs And Devices Market Segment Landscape: Which Areas Lead Development?
The contraceptive drugs and devices market covered in this report is segmented –
1) By Product: Contraceptive Drugs, Contraceptive Devices
2) By Technology: Traditional Methods, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels
4) By End User: Male, Female
Subsegments:
1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants
2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices
Contraceptive Drugs And Devices Market Innovation Trends: What Developments Are Reshaping The Industry?
Leading companies within the contraceptive drugs and devices market are engaged in developing innovative products, such as contraceptive vaginal rings, to enhance user convenience and expand the array of long-acting contraceptive options. A contraceptive vaginal ring is a pliant, hormone-releasing device designed for vaginal insertion to prevent pregnancy by inhibiting ovulation. For instance, in October 2023, Xiromed LLC, a US-based pharmaceutical company, launched EnilloRing, a soft, flexible contraceptive vaginal ring. It is specifically designed for insertion into the vagina, where it steadily releases a combination of etonogestrel (a progestin) and ethinyl estradiol (an estrogen) over three weeks to prevent ovulation. As a bioequivalent generic to NuvaRing, it offers women a convenient, discreet, and cost-effective monthly birth control choice that removes the necessity for daily dosing while maintaining the identical safety, efficacy, and tolerability profile as the branded version.
Contraceptive Drugs And Devices Market Industry Leaders And Competitive Landscape
Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.
View The Full Contraceptive Drugs And Devices Market Report:
Contraceptive Drugs And Devices Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the contraceptive drugs and devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive drugs and devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model